Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-human primate models of PD to test novel therapies
Marc Morissette, Thérèse Di Paolo
Journal of Neural Transmission (2017) Vol. 125, Iss. 3, pp. 291-324
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs
Delphine Charvin, Rossella Medori, Robert A. Hauser, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 11, pp. 804-822
Closed Access | Times Cited: 240
Microglial Implication in Parkinson’s Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions?
Cynthia Lecours, Maude Bordeleau, Léo Cantin, et al.
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 137
Advances in Parkinson’s Disease: 200 Years Later
Natalia López‐González del Rey, Ana Quiroga‐Varela, Elisa Garbayo, et al.
Frontiers in Neuroanatomy (2018) Vol. 12
Open Access | Times Cited: 130
Opportunities and limitations of genetically modified nonhuman primate models for neuroscience research
Guoping Feng, Frances E. Jensen, Henry T. Greely, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 39, pp. 24022-24031
Open Access | Times Cited: 101
Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson’s disease
Gunasingh Masilamoni, Yoland Smith
Journal of Neural Transmission (2017) Vol. 125, Iss. 3, pp. 337-363
Open Access | Times Cited: 63
An mGlu4‐Positive Allosteric Modulator Alleviates Parkinsonism in Primates
Delphine Charvin, Thérèse Di Paolo, Erwan Bézard, et al.
Movement Disorders (2018) Vol. 33, Iss. 10, pp. 1619-1631
Closed Access | Times Cited: 49
Modeling neurodegeneration and neuroinflammation in Parkinson’s Disease: Animal-based strategies
José Á. Morales-García
Methods in cell biology (2025)
Closed Access
Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation
Duraisamy Kempuraj, Govindhasamy Pushpavathi Selvakumar, Ramasamy Thangavel, et al.
Journal of Alzheimer s Disease (2018) Vol. 66, Iss. 3, pp. 1117-1129
Open Access | Times Cited: 34
Genetically engineered animal models of Parkinson's disease: From worm to rodent
Ludivine S. Breger, Marie‐Thérèse Armentero
European Journal of Neuroscience (2018) Vol. 49, Iss. 4, pp. 533-560
Closed Access | Times Cited: 32
One Step Into the Future: New iPSC Tools to Advance Research in Parkinson’s Disease and Neurological Disorders
Nguyen‐Vi Mohamed, Frédérique Larroquette, Lenore K. Beitel, et al.
Journal of Parkinson s Disease (2019) Vol. 9, Iss. 2, pp. 265-281
Open Access | Times Cited: 21
Research advances on L-DOPA-induced dyskinesia: from animal models to human disease
Xi Chen, Yuanyuan Wang, Haifeng Wu, et al.
Neurological Sciences (2020) Vol. 41, Iss. 8, pp. 2055-2065
Closed Access | Times Cited: 20
The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases
Michael Klonarakis, Maya De Vos, Emma K. Woo, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 135, pp. 104541-104541
Closed Access | Times Cited: 11
Assembly of novel microbial genomes from gut metagenomes of rhesus macaque ( Macaca mulatta )
Shengzhi Yang, Zhenxin Fan, Jiawei Li, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Pathophysiology of levodopa-induced dyskinesia: Insights from multimodal imaging and immunohistochemistry in non-human primates
Maude Beaudoin‐Gobert, Élise Météreau, Sandra Duperrier, et al.
NeuroImage (2018) Vol. 183, pp. 132-141
Closed Access | Times Cited: 17
Modeling Parkinson’s Disease: Not Only Rodents?
М. И. Шадрина, P. A. Slominsky
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 13
AV-101, a Pro-Drug Antagonist at the NMDA Receptor Glycine Site, Reduces L-Dopa Induced Dyskinesias in MPTP Monkeys
Mélanie Bourque, Laurent Grégoire, Waseema Patel, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3530-3530
Open Access | Times Cited: 9
Serotonergic innervation of the striatum in a nonhuman primate model of Parkinson's disease
Lorena Jiménez‐Sánchez, Javier Blesa, Natalia López‐González del Rey, et al.
Neuropharmacology (2019) Vol. 170, pp. 107806-107806
Open Access | Times Cited: 15
Dyskinesia and Parkinson’s disease: animal model, drug targets, and agents in preclinical testing
Valentina Cesaroni, Fabio Blandini, Silvia Cerri
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 10, pp. 837-851
Closed Access | Times Cited: 8
Viewpoint: Developing drugs for levodopa‐induced dyskinesia in PD: Lessons learnt, what does the future hold?
Susan H. Fox, Jonathan M. Brotchie
European Journal of Neuroscience (2018) Vol. 49, Iss. 3, pp. 399-409
Closed Access | Times Cited: 14
Comparison of Actions between L-DOPA and Different Dopamine Agonists in Striatal DA-Depleted Microcircuits In Vitro: Pre-Clinical Insights
Esther Lara‐González, Mariana Duhne, Fátima Ávila‐Cascajares, et al.
Neuroscience (2019) Vol. 410, pp. 76-96
Closed Access | Times Cited: 13
Menagerie: A text-mining tool to support animal-human translation in neurodegeneration research
Caroline J. Zeiss, Dongwook Shin, Brent Vander Wyk, et al.
PLoS ONE (2019) Vol. 14, Iss. 12, pp. e0226176-e0226176
Open Access | Times Cited: 12
Pathophysiology of dyskinesia and behavioral disorders in non-human primates: the role of serotonergic fibers
Véronique Sgambato‐Faure, Léon Tremblay
Journal of Neural Transmission (2018) Vol. 125, Iss. 8, pp. 1145-1156
Closed Access | Times Cited: 12
Prior MDMA administration aggravates MPTP-induced Parkinsonism in macaque monkeys
Mathilde Millot, Yosuke Saga, Sandra Duperrier, et al.
Neurobiology of Disease (2019) Vol. 134, pp. 104643-104643
Open Access | Times Cited: 10
Non-human primate research of basal ganglia and movement disorders: advances and challenges
Yoland Smith, Adriana Galván
Journal of Neural Transmission (2018) Vol. 125, Iss. 3, pp. 275-278
Open Access | Times Cited: 7
Deep brain stimulation in Parkinson’s disease patients and routine 6‐OHDA rodent models: Synergies and pitfalls
Alessandro Stefani, Rocco Cerroni, Mariangela Pierantozzi, et al.
European Journal of Neuroscience (2020) Vol. 53, Iss. 7, pp. 2322-2343
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top